Chris Ponting

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search

Professor Chris Pointing (Christopher Paul Pointing) is a British researcher with a special interest in genomics and bioinformatics.[1][2] Prof. Ponting is Section Head at Biomedical Genomics, Chair of Medical Bioinformatics, and a Principal Investigator at the MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine at the University of Edinburgh.[1][2]

In 2018, Professor Ponting replaced Esther Crawley as Deputy Chair of the UK CFS/ME Research Collaborative (CMRC).[3] He is also a long term friend of ME patient and activist Simon McGrath.[4]

Chris has been on the editorial boards of many different research journals and founded CGAT, a training center funded by the UK's Medical Research Council.

Professional organizations[edit | edit source]

  • Fellow of the Academy of Medical Science
  • Member of the European Molecular Biology Organisation

ME/CFS research[edit | edit source]

Professor Ponting is principle investigator on a large study that will use the UK Biobank data to "investigate the biomolecular and genetic bases to myalgic encephalomyelitis (ME/CFS)".[5]

Notable studies[edit | edit source]

Chris Ponting has not published research on ME/CFS yet.

Clinic location[edit | edit source]

Talks and interviews[edit | edit source]

News articles and blogs[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.01.1 "Professor Christopher Paul Ponting FMedSci FRSE". The Royal Society of Edinburgh. Mar 24, 2020. Retrieved Jun 3, 2020. 
  2. 2.02.1 "Professor Chris Ponting". The University of Edinburgh. Retrieved Jun 3, 2020. 
  3. "The CFS/ME Research Collaborative (CMRC) Announces Major Change in Policy and New Deputy Chair | 07 March 2018". ME Association. Mar 7, 2018. Retrieved Jun 3, 2020. 
  4. "Science for ME written Q&A with Prof Chris Ponting". Science for ME. Retrieved Jun 3, 2020. 
  5. "Using UK Biobank data to investigate the biomolecular and genetic bases to myalgic encephalomyelitis (ME/CFS) | UK Biobank". UK Biobank. Retrieved Jun 3, 2020. 

UK CFS/ME Research Collaborative (CMRC) - A UK group of researchers and ME/CFS patient groups led by Professor Stephen Holgate. Its launch in 2013 was covered by the Science Media Centre. Since 2014, the collaborative sponsors the CFS/ME Research Collaborative Conference.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

ME/CFS - An acronym that combines myalgic encephalomyelitis with chronic fatigue syndrome. Sometimes they are combined because people have trouble distinguishing one from the other. Sometimes they are combined because people see them as synonyms of each other.

Action for ME (AfME) - Action for ME is a British non-profit organization that was set up in 1987 as The M.E. Action Campaign. Its founders were Martin Lev, Sue Findlay and Clare Francis. In September 1993 it changed its name and logo to Action for ME and Chronic Fatigue. It then changed its name in 1993 to Action for ME.

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.